Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
8.68
+0.28 (3.27%)
At close: Nov 22, 2024, 4:00 PM
8.70
+0.02 (0.18%)
After-hours: Nov 22, 2024, 7:37 PM EST
Altimmune Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 22, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 617 | 604 | 808 | 363 | 417 | 28 | |
| Market Cap Growth | 218.56% | -25.23% | 122.62% | -12.92% | 1369.44% | 57.35% | |
| Enterprise Value | 480 | 464 | 608 | 165 | 212 | -9 | |
| Last Close Price | 8.68 | 11.25 | 16.45 | 9.16 | 11.28 | 1.89 | |
| PS Ratio | 8391.84 | 1418.90 | -11888.90 | 82.35 | 50.95 | 4.89 | |
| PB Ratio | 4.63 | 3.11 | 4.36 | 1.82 | 1.85 | 0.62 | |
| P/TBV Ratio | 3.27 | 3.11 | 4.68 | 1.94 | 1.96 | 0.87 | |
| EV/Sales Ratio | 9226.05 | 1090.28 | - | 37.39 | 25.91 | - | |
| Debt / Equity Ratio | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.04 | |
| Asset Turnover | 0.00 | 0.00 | - | 0.02 | 0.05 | 0.11 | |
| Quick Ratio | 16.52 | 16.69 | 10.99 | 10.73 | 18.99 | 9.91 | |
| Current Ratio | 16.87 | 17.26 | 11.31 | 11.17 | 19.16 | 10.04 | |
| Return on Equity (ROE) | -72.96% | -46.63% | -44.07% | -45.69% | -36.14% | -43.74% | |
| Return on Assets (ROA) | -39.56% | -25.00% | -25.73% | -22.86% | -16.10% | -22.71% | |
| Return on Capital (ROIC) | -43.44% | -27.38% | -28.31% | -24.76% | -17.52% | -25.70% | |
| Earnings Yield | -16.77% | -14.63% | -10.48% | -26.74% | -11.76% | -72.31% | |
| FCF Yield | -12.65% | -12.55% | -7.76% | -24.88% | -8.28% | -33.84% | |
| Buyback Yield / Dilution | -32.62% | -13.47% | -13.67% | -61.03% | -95.33% | -368.35% | |
| Total Shareholder Return | -32.62% | -13.47% | -13.67% | -61.03% | -95.33% | -368.35% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.